Study of Inflammation in the Skin of Participants with Atopic Dermatitis Treated with Abrocitinib. A Phase 2a, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multicenter Study to Investigate the Mechanism of Action of Abrocitinib Monotherapy in Adult Participants With Moderate-to- Severe Atopic Dermatitis.